Ignite Creation Date:
2025-12-25 @ 1:05 AM
Ignite Modification Date:
2025-12-25 @ 11:17 PM
Study NCT ID:
NCT05164393
Status:
UNKNOWN
Last Update Posted:
2022-01-27
First Post:
2021-11-22
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Phase I/IIa Trial to Evaluate AVX001 Gel in Doses of 1% or 3% Compared With Vehicle Over Four Weeks of Field-directed Treatment Period in Adult Subjects With AK
Sponsor:
Coegin Pharma AB
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-11-02
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-03
Completion Date Type:
ESTIMATED
First Submit Date:
2021-11-22
First Submit QC Date:
None
Study First Post Date:
2021-12-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-26
Last Update Post Date:
2022-01-27
Last Update Post Date Type:
ACTUAL